NEW YORK, November 17, 2025 – Proskauer is pleased to welcome Gregory A. Morris as a partner in its Intellectual Property (IP) and Patent Law Groups in New York. Gregory brings more than two decades of experience across the full spectrum of IP matters, including Hatch-Waxman disputes and inter partes review (IPR) proceedings. A seasoned trial lawyer and Ph.D. chemist, he guides pharmaceutical, biotechnology and medical device companies in complex patent litigation and helps clients secure value by providing strategic IP counseling and due diligence advice.
Gregory’s work includes protecting innovative prescription drugs and biologics across key therapeutic areas, defending high-value patents and challenging competitor claims. Over the course of his career, he has secured landmark decisions that have shaped patent law in the life sciences sector. He has been recognized as a leader in IP by Chambers and Partners, a “Life Sciences Star” by LMG Life Sciences, an “IP Star” by Managing IP and a “Patent Star” by IAM Patent 1000, which ranks him among the world’s leading patent professionals.
“Greg is an accomplished trial lawyer whose scientific background enhances our ability to advise clients,” said Tim Mungovan, Chair of Proskauer. “He understands the business drivers behind life sciences litigation and brings a practical approach that aligns with how our litigators think and advocate for clients.”
“Our clients are operating in an era of rapid scientific and technological change and Greg’s proven track record in patent and IPR litigation, particularly in the pharmaceutical and biotech sectors, immediately strengthens our ability to deliver results,” said Bart Williams, Chair of the Litigation Department. “He also embodies the collaborative and forward-looking mindset that defines our litigation practice.”
“Joining Proskauer gives me the opportunity to build on the strengths of my practice within a Firm that is deeply invested in life sciences and litigation,” said Greg. “The Firm’s integrated platform offers a powerful foundation for helping clients protect and advance their most important technologies.”
About Proskauer
The world’s leading organizations and global players choose Proskauer to represent them when they need it the most. With 800+ lawyers in key financial centers around the world, we are highly regarded for our expertise combined with our pragmatic and commercial approach. Proskauer is the place to turn when a matter is complex, innovative and game-changing. We work seamlessly across practices, industries and jurisdictions with asset managers, private equity and venture capital firms, Fortune 500 and FTSE companies, major sports leagues, entertainment industry legends and other industry-redefining companies.
Proskauer’s multidisciplinary Life Sciences Group brings together the critical skill sets and experience to litigate important intellectual property matters, create and grow life sciences companies, obtain intellectual property rights, raise capital and negotiate and execute strategic deals.
We represent mature pharma and biotech companies in accessing and protecting markets, early-to-later-stage companies in developing new medical technologies, investors in their strategic transactions, as well as universities and other academic or research institutions in realizing commercial value from the innovation of their faculty and research staff. The myriad connections we have in this sector allow us to help clients grow their businesses by gaining access to financing, technology, partners and markets. Working with clients at each stage of their development, our lawyers handle any challenges along the way. Whether raising capital, negotiating licensing agreements or terms of a sale or fighting back patent challenges, our team is equipped to help life sciences companies meet their business goals.